C333H248N20OSi — CID 159172319
4-[4,6-bis[4-(N-phenylanilino)phenyl]-1,3,5-triazin-2-yl]-N,N-diphenylaniline;4-carbazol-9-yl-N-(4-carbazol-9-ylphenyl)-N-phenylaniline;N,N-diphenyl-4-[5-(4-triphenylsilylphenyl)-1,3,4-oxadiazol-2-yl]aniline;2-methyl-4-[3-methyl-4-(4-methyl-N-(4-methylphenyl)anilino)naphthalen-1-yl]-N,N-bis(4-methylphenyl)naphthalen-1-amine;N-[4-[4-(N-naphthalen-1-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-1-amine;N-[4-[4-(N-naphthalen-2-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-2-amine;N-[4-[4-(N-phenanthren-9-ylanilino)phenyl]phenyl]-N-phenylphenanthren-9-amine (PubChem CID 159172319) has the molecular formula C333H248N20OSi and a molecular weight of 4573.87 g/mol. Its IUPAC name is 4-[4,6-bis[4-(N-phenylanilino)phenyl]-1,3,5-triazin-2-yl]-N,N-diphenylaniline;4-carbazol-9-yl-N-(4-carbazol-9-ylphenyl)-N-phenylaniline;N,N-diphenyl-4-[5-(4-triphenylsilylphenyl)-1,3,4-oxadiazol-2-yl]aniline;2-methyl-4-[3-methyl-4-(4-methyl-N-(4-methylphenyl)anilino)naphthalen-1-yl]-N,N-bis(4-methylphenyl)naphthalen-1-amine;N-[4-[4-(N-naphthalen-1-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-1-amine;N-[4-[4-(N-naphthalen-2-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-2-amine;N-[4-[4-(N-phenanthren-9-ylanilino)phenyl]phenyl]-N-phenylphenanthren-9-amine.
| Compound Name | 4-[4,6-bis[4-(N-phenylanilino)phenyl]-1,3,5-triazin-2-yl]-N,N-diphenylaniline;4-carbazol-9-yl-N-(4-carbazol-9-ylphenyl)-N-phenylaniline;N,N-diphenyl-4-[5-(4-triphenylsilylphenyl)-1,3,4-oxadiazol-2-yl]aniline;2-methyl-4-[3-methyl-4-(4-methyl-N-(4-methylphenyl)anilino)naphthalen-1-yl]-N,N-bis(4-methylphenyl)naphthalen-1-amine;N-[4-[4-(N-naphthalen-1-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-1-amine;N-[4-[4-(N-naphthalen-2-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-2-amine;N-[4-[4-(N-phenanthren-9-ylanilino)phenyl]phenyl]-N-phenylphenanthren-9-amine |
|---|---|
| PubChem CID | 159172319 |
| Molecular Formula | C333H248N20OSi |
| Molecular Weight | 4573.87 g/mol |
| Exact Mass | 4569.97 |
| IUPAC Name | 4-[4,6-bis[4-(N-phenylanilino)phenyl]-1,3,5-triazin-2-yl]-N,N-diphenylaniline;4-carbazol-9-yl-N-(4-carbazol-9-ylphenyl)-N-phenylaniline;N,N-diphenyl-4-[5-(4-triphenylsilylphenyl)-1,3,4-oxadiazol-2-yl]aniline;2-methyl-4-[3-methyl-4-(4-methyl-N-(4-methylphenyl)anilino)naphthalen-1-yl]-N,N-bis(4-methylphenyl)naphthalen-1-amine;N-[4-[4-(N-naphthalen-1-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-1-amine;N-[4-[4-(N-naphthalen-2-ylanilino)phenyl]phenyl]-N-phenylnaphthalen-2-amine;N-[4-[4-(N-phenanthren-9-ylanilino)phenyl]phenyl]-N-phenylphenanthren-9-amine |
| SMILES | Cc1ccc(N(c2ccc(C)cc2)c2c(C)cc(-c3cc(C)c(N(c4ccc(C)cc4)c4ccc(C)cc4)c4ccccc34)c3ccccc23)cc1.c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4cc5ccccc5c5ccccc45)cc3)cc2)c2cc3ccccc3c3ccccc23)cc1.c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4ccc5ccccc5c4)cc3)cc2)c2ccc3ccccc3c2)cc1.c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4cccc5ccccc45)cc3)cc2)c2cccc3ccccc23)cc1.c1ccc(N(c2ccc(-n3c4ccccc4c4ccccc43)cc2)c2ccc(-n3c4ccccc4c4ccccc43)cc2)cc1.c1ccc(N(c2ccccc2)c2ccc(-c3nc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)nc(-c4ccc(N(c5ccccc5)c5ccccc5)cc4)n3)cc2)cc1.c1ccc(N(c2ccccc2)c2ccc(-c3nnc(-c4ccc([Si](c5ccccc5)(c5ccccc5)c5ccccc5)cc4)o3)cc2)cc1 |
| InChI | InChI=1S/C57H42N6.C52H36N2.C50H44N2.C44H33N3OSi.2C44H32N2.C42H29N3/c1-7-19-46(20-8-1)61(47-21-9-2-10-22-47)52-37-31-43(32-38-52)55-58-56(44-33-39-53(40-34-44)62(48-23-11-3-12-24-48)49-25-13-4-14-26-49)60-57(59-55)45-35-41-54(42-36-45)63(50-27-15-5-16-28-50)51-29-17-6-18-30-51;1-3-17-41(18-4-1)53(51-35-39-15-7-9-21-45(39)47-23-11-13-25-49(47)51)43-31-27-37(28-32-43)38-29-33-44(34-30-38)54(42-19-5-2-6-20-42)52-36-40-16-8-10-22-46(40)48-24-12-14-26-50(48)52;1-33-15-23-39(24-16-33)51(40-25-17-34(2)18-26-40)49-37(5)31-47(43-11-7-9-13-45(43)49)48-32-38(6)50(46-14-10-8-12-44(46)48)52(41-27-19-35(3)20-28-41)42-29-21-36(4)22-30-42;1-6-16-36(17-7-1)47(37-18-8-2-9-19-37)38-30-26-34(27-31-38)43-45-46-44(48-43)35-28-32-42(33-29-35)49(39-20-10-3-11-21-39,40-22-12-4-13-23-40)41-24-14-5-15-25-41;1-3-17-37(18-4-1)45(43-23-11-15-35-13-7-9-21-41(35)43)39-29-25-33(26-30-39)34-27-31-40(32-28-34)46(38-19-5-2-6-20-38)44-24-12-16-36-14-8-10-22-42(36)44;1-3-15-39(16-4-1)45(43-29-23-33-11-7-9-13-37(33)31-43)41-25-19-35(20-26-41)36-21-27-42(28-22-36)46(40-17-5-2-6-18-40)44-30-24-34-12-8-10-14-38(34)32-44;1-2-12-30(13-3-1)43(31-22-26-33(27-23-31)44-39-18-8-4-14-35(39)36-15-5-9-19-40(36)44)32-24-28-34(29-25-32)45-41-20-10-6-16-37(41)38-17-7-11-21-42(38)45/h1-42H;1-36H;7-32H,1-6H3;1-33H;2*1-32H;1-29H |
| InChIKey | KLVPVSFTBQSIKX-UHFFFAOYSA-N |
| XLogP | 89.44 |
| TPSA | 129.57 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 21 |
| Rotatable Bonds | 54 |
| Heavy Atoms | 355 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4573.87 |
| LogP ≤ 5 | 89.44 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 21 |